PATENT CLAIM ANALYSIS

Application Number: 15749490
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "007230"]

Abstract:
A hybridoma cell line NM002-1 secreting an anti-human pancreatic cancer monoclonal antibody and deposited under CCTCC Accession NO: C201173. Also, an anti-human pancreatic cancer monoclonal antibody NJ002-1 secreted by the hybridoma cell line NM002-1 and use thereof.

Claim (Index 2):
An anti-human pancreatic cancer monoclonal antibody NJ002-1 secreted by the hybridoma cell line NM002-1 deposited under CCTCC Accession NO: C201173 according to  claim 1 .

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.41379
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13985121', '14961106', '12379084', '10279454', '12951718']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5792182438006191
- 35 USC 102 Novelty (BERT): 0.51082172159957
- Combined Prediction Score: 0.5723785915805143
- Mean Citation Score: 226.815978
- Max Citation Score: 229.53677
- Similarity Product: 142.5440151286113

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test